| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
§
From the Gladstone Institute of Neurological Disease,*
the Department of Neurology,
the Gladstone
Institute of Cardiovascular Disease,
and the
Neuroscience Program,§
University of
California, San Francisco, California; and the Departments of
Neurosciences and Pathology,¶
University of
California, San Diego, La Jolla, California
Cerebrovascular amyloid deposition and microvascular degeneration are frequently associated with Alzheimer’s disease (AD), but the etiology and pathogenetic role of these abnormalities are unknown. Recently, transforming growth factor-ß1 (TGF-ß1) was implicated in cerebrovascular amyloid formation in transgenic mice with astroglial overproduction of TGF-ß1 and in AD. We tested whether TGF-ß1 overproduction induces AD-like cerebrovascular degeneration and analyzed how cerebrovascular abnormalities develop over time in TGF-ß1-transgenic mice. In cerebral microvessels from 3- to 4-month-old TGF-ß1-transgenic mice, which display a prominent perivascular astrocytosis, levels of the basement membrane proteins perlecan and fibronectin were severalfold higher than in vessels from nontransgenic mice. Consistent with this increase, cortical capillary basement membranes of TGF-ß1 mice were significantly thickened. These changes preceded amyloid deposition, which began at around 6 months of age. In 9- and 18-month-old TGF-ß1 mice, various degenerative changes in microvascular cells of the brain were observed. Endothelial cells were thinner and displayed abnormal, microvilli-like protrusions as well as occasional condensation of chromatin, and pericytes occupied smaller areas in capillary profiles than in nontransgenic controls. Similar cerebrovascular abnormalities have been reported in AD. We conclude that chronic overproduction of TGF-ß1 triggers an accumulation of basement membrane proteins and results in AD-like cerebrovascular amyloidosis and microvascular degeneration. Closely related processes may induce cerebrovascular pathology in AD.
This article has been cited by other articles:
 |
|
 |
|
  E. Hamel, N. Nicolakakis, T. Aboulkassim, B. Ongali, and X-K. Tong Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease Exp Physiol, January 1, 2008; 93(1): 116 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-K. Tong and E. Hamel Transforming Growth Factor-beta1 Impairs Endothelin-1-Mediated Contraction of Brain Vessels by Inducing Mitogen-Activated Protein (MAP) Kinase Phosphatase-1 and Inhibiting p38 MAP Kinase Mol. Pharmacol., December 1, 2007; 72(6): 1476 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Buckwalter, B. S. Coleman, M. Buttini, R. Barbour, D. Schenk, D. Games, P. Seubert, and T. Wyss-Coray Increased T Cell Recruitment to the CNS after Amyloid beta1-42 Immunization in Alzheimer's Mice Overproducing Transforming Growth Factor-beta1. J. Neurosci., November 1, 2006; 26(44): 11437 - 11441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Buckwalter, M. Yamane, B. S. Coleman, B. K. Ormerod, J. T. Chin, T. Palmer, and T. Wyss-Coray Chronically Increased Transforming Growth Factor-{beta}1 Strongly Inhibits Hippocampal Neurogenesis in Aged Mice Am. J. Pathol., July 1, 2006; 169(1): 154 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Esposito, J. Raber, L. Kekonius, F. Yan, G.-Q. Yu, N. Bien-Ly, J. Puolivali, K. Scearce-Levie, E. Masliah, and L. Mucke Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci., May 10, 2006; 26(19): 5167 - 5179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease J. Neurosci., November 30, 2005; 25(48): 11165 - 11174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cambier, S. Gline, D. Mu, R. Collins, J. Araya, G. Dolganov, S. Einheber, N. Boudreau, and S. L. Nishimura Integrin {alpha}v{beta}8-Mediated Activation of Transforming Growth Factor-{beta} by Perivascular Astrocytes: An Angiogenic Control Switch Am. J. Pathol., June 1, 2005; 166(6): 1883 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Fryer, K. Simmons, M. Parsadanian, K. R. Bales, S. M. Paul, P. M. Sullivan, and D. M. Holtzman Human Apolipoprotein E4 Alters the Amyloid-{beta} 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model J. Neurosci., March 16, 2005; 25(11): 2803 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Love Contribution of cerebral amyloid angiopathy to Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. John, S. C. Lee, and C. F. Brosnan Cytokines: Powerful Regulators of Glial Cell Activation Neuroscientist, February 1, 2003; 9(1): 10 - 22. [Abstract] [PDF]
|
|
|
|
|
|
P. Grammas and R. Ovase Cerebrovascular Transforming Growth Factor-{beta} Contributes to Inflammation in the Alzheimer's Disease Brain Am. J. Pathol., May 1, 2002; 160(5): 1583 - 1587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Docagne, N. Colloc'h, V. Bougueret, M. Page, J. Paput, M. Tripier, P. Dutartre, E. T. MacKenzie, A. Buisson, S. Komesli, et al. A Soluble Transforming Growth Factor-beta (TGF-beta ) Type I Receptor Mimics TGF-beta Responses J. Biol. Chem., November 30, 2001; 276(49): 46243 - 46250. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
